FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131530054> ?p ?o ?g. }

• W3131530054 endingPage "1107" @default.
• W3131530054 startingPage "1093" @default.
• W3131530054 abstract "Abstract STUDY QUESTION Does fertility treatment (FT) significantly increase the incidence of breast, ovarian, endometrial or cervical cancer? SUMMARY ANSWER Overall, FT does not significantly increase the incidence of breast, ovarian or endometrial cancer and may even reduce the incidence of cervical cancer. WHAT IS KNOWN ALREADY Infertility affects more than 14% of couples. Infertility and nulliparity are established risk factors for endometrial, ovarian and breast cancer, yet the association with FT is more contentious. STUDY DESIGN, SIZE, DURATION A literature search was carried out using Cochrane Library, EMBASE, Medline and Google Scholar up to December 2019. Peer-reviewed studies stating cancer incidence (breast, ovarian, endometrial or cervical) in FT and no-FT groups were identified. Out of 128 studies identified, 29 retrospective studies fulfilled the criteria and were included (n = 21 070 337). PARTICIPANTS/MATERIALS, SETTING, METHODS In the final meta-analysis, 29 studies were included: breast (n = 19), ovarian (n = 19), endometrial (n = 15) and cervical (n = 13), 17 studies involved multiple cancer types and so were included in each individual cancer meta-analysis. Primary outcome of interest was cancer incidence (breast, ovarian, endometrial and cervical) in FT and no-FT groups. Secondary outcome was cancer incidence according to specific fertility drug exposure. Odds ratio (OR) and random effects model were used to demonstrate treatment effect and calculate pooled treatment effect, respectively. A meta-regression and eight sub-group analyses were performed to assess the impact of the following variables, maternal age, infertility, study size, outliers and specific FT sub-types, on cancer incidence. MAIN RESULTS AND THE ROLE OF CHANCE Cervical cancer incidence was significantly lower in the FT group compared with the no-FT group: OR 0.68 (95% CI 0.46–0.99). The incidences of breast (OR 0.86; 95% CI 0.73–1.01) and endometrial (OR 1.28; 95% CI 0.92–1.79) cancers were not found to be significantly different between the FT and no-FT groups. Whilst overall ovarian cancer incidence was not significantly different between the FT and no-FT groups (OR 1.19; 95% CI 0.98–1.46), separate analysis of borderline ovarian tumours (BOT) revealed a significant association (OR 1.69; 95% CI 1.27–2.25). In further sub-group analyses, ovarian cancer incidence was shown to be significantly higher in the IVF (OR 1.32; 95% CI 1.03–1.69) and clomiphene citrate (CC) treatment group (OR 1.40; 95% CI 1.10–1.77), respectively when compared with the no-FT group. Conversely, the incidences of breast (OR 0.75; 95% CI 0.61–0.92) and cervical cancer (OR 0.58; 95% CI 0.38–0.89) were significantly lower in the IVF treatment sub-group compared to the no-FT group. LIMITATIONS, REASONS FOR CAUTION The large, varied dataset spanning a wide study period introduced significant clinical heterogeneity. Thus, results have to be interpreted with an element of caution. Exclusion of non-English citations, unpublished work and abstracts, in order to ensure data accuracy and reliability was maintained, may have introduced a degree of selection bias. WIDER IMPLICATIONS OF THE FINDINGS The results for breast, ovarian, endometrial and cervical cancer are reassuring, in line with previously published meta-analyses for individual cancers but the association between IVF and CC treatment and an increase in ovarian cancer incidence requires additional work to understand the potential mechanism driving this association. In particular, focusing on (i) discriminating specific treatments effects from an inherent risk of malignancy; (ii) differential risk profiles among specific patient sub-groups (refractory treatment and obesity); and (iii) understanding the impact of FT outcomes on cancer incidence. STUDY FUNDING/COMPETING INTEREST(S) This study did not receive any funding. The authors have no financial, personal, intellectual and professional conflicts of interest to declare. PROSPERO REGISTRATION NUMBER CRD42019153404." @default.
• W3131530054 created "2021-03-01" @default.
• W3131530054 creator A5000035949 @default.
• W3131530054 creator A5021936704 @default.
• W3131530054 creator A5036109835 @default.
• W3131530054 creator A5047403498 @default.
• W3131530054 creator A5058597472 @default.
• W3131530054 creator A5059707543 @default.
• W3131530054 creator A5060963992 @default.
• W3131530054 creator A5063272979 @default.
• W3131530054 creator A5063747532 @default.
• W3131530054 creator A5066367472 @default.
• W3131530054 creator A5067417381 @default.
• W3131530054 creator A5069281509 @default.
• W3131530054 creator A5078409154 @default.
• W3131530054 creator A5079623486 @default.
• W3131530054 creator A5082338017 @default.
• W3131530054 creator A5091358721 @default.
• W3131530054 date "2021-02-15" @default.
• W3131530054 modified "2023-10-03" @default.
• W3131530054 title "Fertility treatment and cancers—the eternal conundrum: a systematic review and meta-analysis" @default.
• W3131530054 cites W1566586551 @default.
• W3131530054 cites W1635300228 @default.
• W3131530054 cites W1799526768 @default.
• W3131530054 cites W1965638205 @default.
• W3131530054 cites W1966371456 @default.
• W3131530054 cites W1970738847 @default.
• W3131530054 cites W1971554308 @default.
• W3131530054 cites W1973901345 @default.
• W3131530054 cites W1975572878 @default.
• W3131530054 cites W1979423827 @default.
• W3131530054 cites W1982072595 @default.
• W3131530054 cites W1995582002 @default.
• W3131530054 cites W2002631438 @default.
• W3131530054 cites W2007005555 @default.
• W3131530054 cites W2012413910 @default.
• W3131530054 cites W2018504851 @default.
• W3131530054 cites W2020794451 @default.
• W3131530054 cites W2037828933 @default.
• W3131530054 cites W2040658711 @default.
• W3131530054 cites W2045387089 @default.
• W3131530054 cites W2054572564 @default.
• W3131530054 cites W2056833186 @default.
• W3131530054 cites W2061855760 @default.
• W3131530054 cites W2062246770 @default.
• W3131530054 cites W2062637797 @default.
• W3131530054 cites W2064922137 @default.
• W3131530054 cites W2070369494 @default.
• W3131530054 cites W2071276232 @default.
• W3131530054 cites W2071540706 @default.
• W3131530054 cites W2075938228 @default.
• W3131530054 cites W2079666117 @default.
• W3131530054 cites W2093650348 @default.
• W3131530054 cites W2094847769 @default.
• W3131530054 cites W2099232726 @default.
• W3131530054 cites W2099331063 @default.
• W3131530054 cites W2101463348 @default.
• W3131530054 cites W2108217153 @default.
• W3131530054 cites W2109879670 @default.
• W3131530054 cites W2112242311 @default.
• W3131530054 cites W2114032759 @default.
• W3131530054 cites W2120039304 @default.
• W3131530054 cites W2120456225 @default.
• W3131530054 cites W2125435699 @default.
• W3131530054 cites W2125597009 @default.
• W3131530054 cites W2126939811 @default.
• W3131530054 cites W2129069810 @default.
• W3131530054 cites W2129546497 @default.
• W3131530054 cites W2132854918 @default.
• W3131530054 cites W2133417020 @default.
• W3131530054 cites W2134589371 @default.
• W3131530054 cites W2136297604 @default.
• W3131530054 cites W2136927737 @default.
• W3131530054 cites W2137314161 @default.
• W3131530054 cites W2137849078 @default.
• W3131530054 cites W2139652947 @default.
• W3131530054 cites W2140866731 @default.
• W3131530054 cites W2141759827 @default.
• W3131530054 cites W2145640698 @default.
• W3131530054 cites W2148400658 @default.
• W3131530054 cites W2148937722 @default.
• W3131530054 cites W2152859757 @default.
• W3131530054 cites W2153050474 @default.
• W3131530054 cites W2153622681 @default.
• W3131530054 cites W2156794509 @default.
• W3131530054 cites W2158309411 @default.
• W3131530054 cites W2161269408 @default.
• W3131530054 cites W2161701454 @default.
• W3131530054 cites W2161703496 @default.
• W3131530054 cites W2161861786 @default.
• W3131530054 cites W2166538683 @default.
• W3131530054 cites W2169702911 @default.
• W3131530054 cites W2170869572 @default.
• W3131530054 cites W2253795040 @default.
• W3131530054 cites W2281191439 @default.
• W3131530054 cites W2315888143 @default.
• W3131530054 cites W2399717049 @default.
• W3131530054 cites W2486269942 @default.

• next